Additionally, a study by Ryu et al. [67] demonstrated the ameliorative effect of NAC against airway inflammation in cystic fibrosis patients through its inhibition of NF-κB nuclear translocation. This evidence concerns the gene NFKB1 and cystic fibrosis.